Vitamin B12 Deficiency (Hypocobalaminemia) Ongoing Global Clinical Trials Analysis and Outlook

June 2018 | 31 pages | ID: V3B69E8512BEN
VPAResearch

Abstracts

Vitamin B12 Deficiency (Hypocobalaminemia) ongoing clinical trials report from VPA Research provides comprehensive analysis and trends in global Vitamin B12 Deficiency (Hypocobalaminemia) disease clinical trials. The research work analyzes the ongoing Vitamin B12 Deficiency (Hypocobalaminemia) clinical trial trends across countries and companies.

The report focuses on drugs and therapies being evaluated for Vitamin B12 Deficiency (Hypocobalaminemia) treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, enrollment, phases, trial status and sponsor types.

Our experienced database team dynamically updates the clinical trials data from several sources including Clinical trial registries, conferences, journals and company releases etc. Further, data is presented in user friendly manner to enable readers quick access to Vitamin B12 Deficiency (Hypocobalaminemia) clinical trials.

Scope of the Report-

• Ongoing Vitamin B12 Deficiency (Hypocobalaminemia) clinical trials across regions
• Trial information by Phase and Subjects recruited
• Trial information by status, type, sponsor type
• Drugs used for treatment of Vitamin B12 Deficiency (Hypocobalaminemia)
• Both observational and interventional trials analyzed
• Leading companies and universities participating in Vitamin B12 Deficiency (Hypocobalaminemia) clinical trials

Reasons to Buy

• Track competition and design competitive advantages
• Identify right partners to associate with for further research
• Evaluate potential opportunities available in further clinical trials of the disease
• Formulate business development strategies through success rates of clinical trials
• Identify quick markets for recruiting subjects based on trials count by each market

Contents

1 TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2 KEY FINDINGS, 2018

2.1 Snapshot
2.2 Overview of Vitamin B12 Deficiency (Hypocobalaminemia) Trials

3 CLINICAL TRIALS TRENDS TO 2022

3.1 Ongoing Vitamin B12 Deficiency (Hypocobalaminemia) Trials by Phase
3.2 Ongoing Vitamin B12 Deficiency (Hypocobalaminemia) Trials by Type
3.3 Ongoing Vitamin B12 Deficiency (Hypocobalaminemia) Trials by Recruitment Status

4 COUNTRY LEVEL ANALYSIS

4.1 Region wise Ongoing Vitamin B12 Deficiency (Hypocobalaminemia) Trials
4.2 Top 10 Countries conducting Vitamin B12 Deficiency (Hypocobalaminemia) Trials
4.3 Trials in Emerging and Developing Economies

5 COMPANY LEVEL ANALYSIS

5.1 Ongoing Vitamin B12 Deficiency (Hypocobalaminemia) Trials by Sponsor Type
5.2 Vitamin B12 Deficiency (Hypocobalaminemia) Subjects by Sponsor Type
5.3 Subjects Recruited by Leading Sponsors

6 ENROLMENT TRENDS TO 2022

6.1 Subjects Recruited for Vitamin B12 Deficiency (Hypocobalaminemia) Trials by year
6.2 Subjects Recruited for Vitamin B12 Deficiency (Hypocobalaminemia) Trials by Phase
6.3 Subjects Recruited for Vitamin B12 Deficiency (Hypocobalaminemia) Trials by Trial Type
6.4 Subjects Recruited for Vitamin B12 Deficiency (Hypocobalaminemia) Trials by Recruitment Status

7 ONGOING TRIALS- PHASE, ID, TITLE, LOCATION, TYPE, DURATION, RECRUITMENT STATUS, COMPANY DETAILS

7.1 Ongoing Vitamin B12 Deficiency (Hypocobalaminemia) Trials- Phase
7.2 Ongoing Vitamin B12 Deficiency (Hypocobalaminemia) Trials- Phase
7.3 Ongoing Vitamin B12 Deficiency (Hypocobalaminemia) Trials- Phase
7.4 Ongoing Vitamin B12 Deficiency (Hypocobalaminemia) Trials- Phase

8 APPENDIX

8.1 Abbreviations and Definitions
8.2 Sources and Research Methodology

List Of Figures

LIST OF FIGURES

Figure 1: Vitamin B12 Deficiency (Hypocobalaminemia)- Clinical Trials by Country
Figure 2: Vitamin B12 Deficiency (Hypocobalaminemia)- Clinical Trials by Phase of Development, 2018
Figure 3: Vitamin B12 Deficiency (Hypocobalaminemia)- Clinical Trials by Status, 2018
Figure 4: Vitamin B12 Deficiency (Hypocobalaminemia)- Clinical Trials by Type, 2018
Figure 5: Vitamin B12 Deficiency (Hypocobalaminemia)- Clinical Trials Split by Region, 2000-2018
Figure 6: Vitamin B12 Deficiency (Hypocobalaminemia)- Clinical Trials by Type of Economy, 2018
Figure 7: Vitamin B12 Deficiency (Hypocobalaminemia)- Enrolment by Phase, 2018
Figure 8: Vitamin B12 Deficiency (Hypocobalaminemia)- Enrolment by Trial Type, 2018
Figure 9: Vitamin B12 Deficiency (Hypocobalaminemia)- Enrolment by Recruitment Status, 2018
Figure 10: Vitamin B12 Deficiency (Hypocobalaminemia)- Clinical Trials by Sponsor Type, 2018
Figure 11: Vitamin B12 Deficiency (Hypocobalaminemia)- Enrolment by Type of Sponsors
Figure 12: Vitamin B12 Deficiency (Hypocobalaminemia)- Enrolment by Leading Sponsors

List Of Tables

LIST OF TABLES

Table 1: Vitamin B12 Deficiency (Hypocobalaminemia)- Clinical Trials by Sponsor Type, 2018
Table 2: Vitamin B12 Deficiency (Hypocobalaminemia)- Clinical Trials by Economy Type, 2018
Table 3: Vitamin B12 Deficiency (Hypocobalaminemia)- Clinical Trials by Region, 2018
Table 4: Vitamin B12 Deficiency (Hypocobalaminemia)- Clinical Trial Participations of Top 10 Countries, 2018
Table 5: Vitamin B12 Deficiency (Hypocobalaminemia)- Clinical Trials in Emerging and Developing Economies, 2018
Table 6: Vitamin B12 Deficiency (Hypocobalaminemia)- Ongoing Phase 1 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 7: Vitamin B12 Deficiency (Hypocobalaminemia)- Ongoing Phase 2 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 8: Vitamin B12 Deficiency (Hypocobalaminemia)- Ongoing Phase 3 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 9: Vitamin B12 Deficiency (Hypocobalaminemia)- Ongoing Phase 4 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company